North East, USA

Short Summary

Skypiatrist; A platform that enables outpatient psychiatrists to build their own telemedicine practice; Approaching $1M in recurring revenues; 10k+ patient sessions; Partnerships with United/Optum, Aetna, Cigna; Experience team; Already raised $25k+


Investment Raised
Previous Rounds N/A
Stage Breaking Even
Investor Role Any


  • Approaching $1M in annual revenues
  • 12%+ MoM growth
  • Founding Team - Board Certified Physician & experienced entrepreneur
  • 10,000+ patient sessions
  • Partnerships with United/Optum, Aetna, Cigna
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
0% raised


location_on Midwest, USA

New Gold Standard: Transforming ACL Reconstruction Surgery: Superior strength · Reduced pain · Improved aesthetics · Reduced rehabilitation - Patented, Clinically tested technology. No additional FDA clearance required.

US$ 1,000,000


US$ 100,000

Min per Investor

Global Pro
0% raised

New COVID-19 Test

location_on West, USA

We at American Made DiagnoStiks® have developed the IQStik®, a saliva-based COVID-19 test that can deliver results in just 5 minutes. We're looking for angel investors to help fund the mass production of the IQStik® for global distribution.

US$ 10,000,000


US$ 50,000

Min per Investor

32% raised

CellX Technologies

location_on North East, USA

Cell X Technologies, Inc. is a spin-out of the Cleveland Clinic by Dr George Muschler. “Cell X”, is an automated robotic cell processing platform, designed and engineered in collaboration with Parker Hannifin Corporation.

US$ 2,500,000


US$ 10,000

Min per Investor

load one similar proposal